1. The purification of monoamine oxidase and diamine oxidase from normal human term placental tissue is described. 2. The properties of these enzymes are reported and compared with the properties of unpurified human pregnancy plasma. 3. This comparison shows that the amine oxidase of pregnancy plasma has properties corresponding to purified placental diamine oxidase, suggesting a placental origin for the plasma enzyme system. 4. Detailed kinetic study of the purified placental diamine oxidase suggests that it has a Ping Pong sequence, a mechanism of action and rate-limiting step similar to the diamine oxidase of pig kidney. 5. It is suggested that the enzyme system is important in protecting the foeto-placental unit from excesses of biogenic amines.
The presence of a monoamine oxidase (EC 1.4.3.4) (Thompson & Tickner, 1949) , diamine oxidase (EC 1.4.3.6) (Danforth & Gorham, 1937) and insoluble mitochondrial monoamine oxidase (Youdim & Sandler, 1967) have been reported in human placental tissue, and the diamine oxidase has been partially purified (Smith, 1967; Paolucci et al., 1971) . We have isolated and purified an enzyme from normal term placentae which, though being in many ways a typical monoamine oxidase, was nevertheless able to oxidize some diamines and was found to be soluble, properties usually associated with diamine oxidase . However, the erroneous conclusion was drawn that this enzyme in fact accounted for both the diamine and monoamine oxidase activities of human placentae, but after a more detailed study of placental amine oxidases we have been able to isolate and purify an enzyme with typical diamine oxidase properties. We now report the properties of the purified monoamine oxidase and diamine oxidase of human placentae together with some observations on the amine oxidase activity of human pregnancy plasma.
Experimental Assay ofdiamine oxidase activity
The direct spectrophotometric method for assaying diamine oxidase (Bardsley et al., 1972) was more sensitive and versatile than the indirect methods (Holmstedt & Tham, 1959; Holmstedt et al., 1961; McEwen, 1965) for the measurement of enzyme activity in plasma, during enzyme preparations and for kinetic analysis. The measurement of oxidation of substrates was by coupled oxidation of o-dianisidine by peroxidase and H202 as described by McEwen (1965) . A number of aromatic amines Vol. 139 were also tested by measurement ofthe corresponding aldehyde produced, and where this was appreciable (o-, m- (CM 50). The enzyme was eluted with 0.02M buffer, the active fractions were pooled ( Fig. la) Table 3 . Suibstrate specificities for placental monoamine oxidase, placental diamine oxidase and pregnancy-plasma diamine oxidase, together with valuesfor placental diamine oxidase given by Smith (1967) Placental diamine oxidase (Smith, 1967) Placental diamine oxidase (Paolucci et al., 1971) 19 (15puM) 
Enzyme concentration
The enzyme concentrations used in the present study were as follows: placental monoamine oxidase 0.005 unit/ml; placental diamine oxidase, 0.02 unit/ml; pregnancy-plasma diamine oxidase, 0.00027 unit/ml.
The concentrations of both the placental monoamine oxidase and diamine oxidase approximated to those found in the placental cytoplasm under physiological conditions.
Owing to its high absorbance, it was necessary to dilute the unpurified pregnancy plasma 1:15 for spectrophotometric assays.
Kinetic isotope effect
This was studied by using p-dimethyl-aa-bisdeuteriobenzylamine as described by .
Results Tables 1 and 2 show typical preparations ofmonoamine oxidase and diamine oxidase from human term placentae. We have found considerable variation in the activities of these enzymes in individual placentae Vol. 139 (W. G. Bardsley, M. J. C. Crabbe & I. V. Scott, unpublished work), but conclude that this is not affected by the time delay in obtaining placentae, i.e. whether the placentae were obtained by section or by vaginal delivery. The most serious obstacle to purification was discovered to be blood clotting, and it was found best to avoid this by exsanguinating as soon as possible, after which the placentae could be stored indefinitely at -15°C. Table 3 gives information on some of the most important potential substrates for these enzymes. From this information and also from results with a further 50 potential substrates it seems that placental monoamine oxidase has a typical monoamine oxidase substrate specificity, except that some diamines and polyamines were weakly oxidized. We consider that this is not due to contamination with diamine oxidase, as it is not affected by amino guanidine. It is particularly interesting that, of the aromatic amines tested (including benzylamine and p -dimethylaminobenzylamine), p -dimethylaminomethylbenzylamine was the best compound for use in a spectrophotometric assay. We had hitherto thought of this compound as more specific for diamine oxidase. The placental diamine oxidase has a substrate specificity which corresponds closely to the classical pig kidney diamine oxidase and this is also approximately true for unpurified pregnancy plasma.
The inhibitor specificities in Table 4 show that the placental monoamine oxidase and diamine oxidase correspond to classical types in this respect, except 1W. G. BARDSLEY, M. J. C. CRABBE AND I. V. SCOTT for the unexpected inhibition of the plasma and placental diamine oxidases by so-called monoamine oxidase inhibitors. Table 5 summarizes the properties of the monoamine and diamine oxidases and pregnancy plasma. Fig. 1 illustrates the purification of placental monoamine and diamine oxidase and the separation from inactive protein and haemoprotein (E408) achieved by column chromatography. Fig. 2 shows the oxidation of aromatic amines by placental monoamine oxidase and diamine oxidase as determined spectrophotometrically. Most of the amines studied would be of limited value in spectrophotometric assay procedures owing to the high degree of substrate inhibition given by them. From these double-reciprocal plots it seems thatp-dimethylaminomethylbenzylamine is the most useful substrate for spectrophotometric assay of both placental monoamine and diamine oxidase and pregnancy plasma. A development of this method (W. G. Bardsley, M. J. C. Crabbe & I. V. Scott, unpublished work) for assay of pregnancy-plasma amine oxidase has been successfully accomplished and is now in use for routine screening of pregnant women. Fig. 3 shows that double-reciprocal plots with several values for the fixed substrate are a family of parallel lines whichever substrate is fixed. This suggests a catalytic sequence involving only binary enzyme-substrate complexes, i.e. a Ping Pong Bi Ter mechanism.
The product-inhibition patterns shown in Fig. 4 (aminoaldehyde, non-competitive; H202, uncompetitive; NH3, competitive) are in accordance with an obligatory ordered release of products where the aminoaldehyde is released first (P) followed by H202 (Q) and NH3 (R) (see the Discussion section).
To many of the better known monoamine oxidase inhibitors also inhibit the diamine oxidases from both the human placenta and pig kidney. Vol. 139 study of the effect of metal ion-chelating agents on metalloenzymes , if the chelating agent removes y metal ions from the enzyme to form a chelate complex where the ratio of chelating agent to metal ion is x, then with the degree of dissociation of metalloenzyme = A we have: can be determined by assuming that enzyme activity in the absence of inhibitor is proportional to [Eo] and in the presence of inhibitor is proportional to [E] .
Our results with the diamine oxidase of pig kidney show that this enzyme reacts instantaneously with chelating agent to reach an equilibrium position dictated solely by inhibitor concentration. A plot of A against [I] was sigmoid, and it 5000 was found that 2Cu2+ ions were removed to form chelate complexes which in all cases had the maximum ratio of chelating agent to metal ion, i.e. K2 was the cumulative equilibrium constant for the chelating system.
The results with 1,10-phenanthroline show that placental diamine oxidase behaves in exactly the same way as the pig kidney diamine oxidase. The K1=4.06xl-136mol litre-1 or 3Cu2+ ions with K1 = 9.2x 10-56moI * litre-t.
Discussion
It seems clear from the results of the present paper that the human placenta elaborates two soluble amine oxidases. One is a diamine oxidase which appears to resemble the classical diamine oxidase of pig kidney in its properties, and the other is an enzyme with typical monoamine oxidase properties except that it is soluble, cytoplasmic in origin and oxidizes many diamines, albeit rather weakly compared with the best substrates (catecholamines). The properties of the diamine oxidase of pregnancy plasma seem closely similar to those of placental diamine oxidase, and this supports the hypothesis that the plasma 1974 180 501 enzyme activity does in fact originate in the placenta. We have some reservations about this conclusion, however, since diamine oxidase activities in plasma may not correlate with activities in individual placentae and, more seriously, diamine oxidase activity can be detected in some non-pregnant women and sometimes even in males (W. G. Bardsley, M. J. C. Crabbe & I. V. Scott, unpublished work).
It is of some interest that the kinetic study of the purified placental diamine oxidase seems to indicate a Ping Pong Bi Ter mechanism with the sequence: 
where A is diamine, B is oxygen, Pis aminoaldehyde, Q is H202 and R is NH3. Further, the deuterium isotope effect locates the rate-determining step in the sequenceEA -+ FP, and this indicates that theenzyme is closely similar to the diamine oxidase of pig kidney . It is of interest that the kinetic isotope effect with the placental diamine oxidase was much smaller than that with the placental monoamine oxidase, which may have some mechanistic significance. An interesting feature of the productinhibition patterns is that the slope and intercept replots for the aminoaldehyde and H202 indicate that the inhibition is described by a polynomial in inhibitor concentration of degree greater than one, i.e. the product inhibition is also accompanied by dead-end inhibition and/or partial inhibition. We have discussed the possible functional significance of this enzyme system in pregnancy as a protection for the foetoplacental unit. Concentrations of biogenic amines could become elevated if the oxygen partial pressure in the placenta fell too low, leading to placental damage, and it is important to inquire as to the utilization of 02 by these enzymes. Some information is now available about the placental diamine oxidase. This has an apparent Km for O°of 0.29 mm. Defining Vmax. as the velocity with saturating conditions of both 02 and amine, then with amine saturating the percentage of Vmax. given at various 02 concentrations would be approximately air (50 %Vmax.), 3% 02 (18% Vmax.) and 1% 02 (8% Vmax.). The normal range of 02 partial pressure encountered in pregnancy is 11.8 % 02 (pO2 = 12000Pa) in the maternal arterioles to 2.6% 02 (p02 = 2700 Pa) in the umbilical artery. It is thus obvious that diamine oxidase is operating in the placenta within a fairly critical oxygen concentration range. Any fall in 02 partial pressure owing to diminished circulation could render the protective function ineffective, leading to polyamine accumulation and subsequent compromise to the vasomotor stability of the placental microcirculation.
